Long-term Follow-up Study Following the Approval of Hearticellgram-AMI Administration

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorPharmicell Co., Ltd.

About this trial

This Long-term follow-up is designed to evaluate the safety of patient with Acute Myocardial Infarction who had administered Hearticellgram-AMI.

Those who had administered Hearticellgram-AMI

Those who voluntarily agreed in writing to participate in this investigation

None

100 Participants

are divided into 1 treatment group

Pharmicell Co., Ltd.

Lead sponsor